1. Home
  2. SUPN vs USA Comparison

SUPN vs USA Comparison

Compare SUPN & USA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SUPN
  • USA
  • Stock Information
  • Founded
  • SUPN 2005
  • USA 1986
  • Country
  • SUPN United States
  • USA United States
  • Employees
  • SUPN N/A
  • USA N/A
  • Industry
  • SUPN Biotechnology: Pharmaceutical Preparations
  • USA Finance Companies
  • Sector
  • SUPN Health Care
  • USA Finance
  • Exchange
  • SUPN Nasdaq
  • USA Nasdaq
  • Market Cap
  • SUPN 2.1B
  • USA 2.0B
  • IPO Year
  • SUPN 2012
  • USA N/A
  • Fundamental
  • Price
  • SUPN $37.74
  • USA $7.13
  • Analyst Decision
  • SUPN Hold
  • USA
  • Analyst Count
  • SUPN 1
  • USA 0
  • Target Price
  • SUPN $36.00
  • USA N/A
  • AVG Volume (30 Days)
  • SUPN 376.5K
  • USA 880.5K
  • Earning Date
  • SUPN 02-25-2025
  • USA 01-01-0001
  • Dividend Yield
  • SUPN N/A
  • USA 9.66%
  • EPS Growth
  • SUPN 130.79
  • USA N/A
  • EPS
  • SUPN 1.07
  • USA N/A
  • Revenue
  • SUPN $651,972,000.00
  • USA N/A
  • Revenue This Year
  • SUPN $7.82
  • USA N/A
  • Revenue Next Year
  • SUPN N/A
  • USA N/A
  • P/E Ratio
  • SUPN $35.28
  • USA N/A
  • Revenue Growth
  • SUPN 6.79
  • USA N/A
  • 52 Week Low
  • SUPN $25.53
  • USA $5.62
  • 52 Week High
  • SUPN $39.37
  • USA $7.09
  • Technical
  • Relative Strength Index (RSI)
  • SUPN 57.78
  • USA 54.66
  • Support Level
  • SUPN $36.48
  • USA $6.80
  • Resistance Level
  • SUPN $38.68
  • USA $7.17
  • Average True Range (ATR)
  • SUPN 1.06
  • USA 0.10
  • MACD
  • SUPN 0.09
  • USA 0.02
  • Stochastic Oscillator
  • SUPN 68.46
  • USA 82.50

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

About USA Liberty All-Star Equity Fund

Liberty All Star Equity Fund is a closed-end funds and open-end multi-managed fund. Its objective is to provide a high level of current income and long-term capital appreciation through investing primarily in a diversified portfolio of equity securities. The fund invests in various sectors, including financials, information technology, healthcare, consumer discretionary, consumer staples, industrials, energy, materials, real estate, utilities, telecommunication and other services.

Share on Social Networks: